Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Revenue - Disaggregation of Revenue (Details)

v3.24.1.1.u2
Note 5 - Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 17,493 $ 2,876
Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member]    
Revenue 11,324 0
Pharmacy 340B Contract [Member]    
Revenue 3,304 0
E-Commerce Revenue [Member]    
Revenue 17,493  
E-Commerce Revenue [Member] | Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member]    
Revenue 11,324  
E-Commerce Revenue [Member] | E-Commerce [Member]    
Revenue 2,865  
E-Commerce Revenue [Member] | Pharmacy Prescription, Other Revenue and E-Commerce [Member]    
Revenue 14,189  
E-Commerce Revenue [Member] | Pharmacy 340B Contract [Member]    
Revenue $ 3,304  
Healthcare Operations [Member]    
Revenue   2,876
Healthcare Operations [Member] | Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member]    
Revenue   0
Healthcare Operations [Member] | E-Commerce [Member]    
Revenue   2,876
Healthcare Operations [Member] | Pharmacy Prescription, Other Revenue and E-Commerce [Member]    
Revenue   2,876
Healthcare Operations [Member] | Pharmacy 340B Contract [Member]    
Revenue   $ 0